Trending

#Trulicity

Latest posts tagged with #Trulicity on Bluesky

Latest Top
Trending
#Vaccine Policy #DLSS 5 #Oscars #Strait of Hormuz #Sonic Racing #Ukraine Conflict #MJF Tribute #Javier Bardem #Marty Supreme #WBC #Vaccine Policy #DLSS 5 #Oscars #Strait of Hormuz #Sonic Racing #Ukraine Conflict #MJF Tribute #Javier Bardem #Marty Supreme #WBC

Posts tagged #Trulicity

Oregon Coalition for Affordable Prescriptions
Oregon Coalition for Affordable Prescriptions
@affordablerxor.bsky.social
2 months ago
A green background with a white border. White text at the top says: 2025 Annual Report Below text says: The board voted to approve the 2025 Annual Report for the Oregon Legislature. The report outlines the board's activities, price trend analyses, and policy recommendations to improve drug affordability across Oregon. To the right is a screenshot of the yellow report cover with a photo of a family.

A green background with a white border. White text at the top says: 2025 Annual Report Below text says: The board voted to approve the 2025 Annual Report for the Oregon Legislature. The report outlines the board's activities, price trend analyses, and policy recommendations to improve drug affordability across Oregon. To the right is a screenshot of the yellow report cover with a photo of a family.

A green background with a white border. White text at the top says: 2025 Affordability Reviews. Below text says: Board members identified several top priority drugs that present significant affordability challenges for Oregonians: Cosentyx Creon Vraylar Trulicity Lantus SoloStar Their final vote will be at their January 21 meeting. Icons of an injection, pills, and a price tag with three dollar signs.

A green background with a white border. White text at the top says: 2025 Affordability Reviews. Below text says: Board members identified several top priority drugs that present significant affordability challenges for Oregonians: Cosentyx Creon Vraylar Trulicity Lantus SoloStar Their final vote will be at their January 21 meeting. Icons of an injection, pills, and a price tag with three dollar signs.

A green background with a white border. White text at the top says: Next Year. Below text says: The board is already preparing for 2026 affordability reviews, developing a preliminary list of 137 drug products for review based on 2024 data. To ensure patient voices are heard, a major outreach project will launch in spring of 2026 with community meetings in Salem, Redmond, Portland, and Beaverton, and online. An icon of the state of Oregon with hands raised inside. A speech bubble coming from the state with a pill bottle and a price tag with three dollar signs.

A green background with a white border. White text at the top says: Next Year. Below text says: The board is already preparing for 2026 affordability reviews, developing a preliminary list of 137 drug products for review based on 2024 data. To ensure patient voices are heard, a major outreach project will launch in spring of 2026 with community meetings in Salem, Redmond, Portland, and Beaverton, and online. An icon of the state of Oregon with hands raised inside. A speech bubble coming from the state with a pill bottle and a price tag with three dollar signs.

A green background with a white border. White text at the top says: Looking Ahead. White text below says: Next PDAB Meeting: January 21, 2026 at 8 am, Register for Zoom Link. Board members will vote on the final list of unaffordable drugs from their 2025 affordability reviews. A white icon of a calendar with the date January 21.

A green background with a white border. White text at the top says: Looking Ahead. White text below says: Next PDAB Meeting: January 21, 2026 at 8 am, Register for Zoom Link. Board members will vote on the final list of unaffordable drugs from their 2025 affordability reviews. A white icon of a calendar with the date January 21.

This Wednesday the #Oregon #PDAB met. Here are the highlights:
- Annual Report
- 2025 #Affordability Reviews
- Next Year's Plan

Next meeting: Jan 21, 2026 at 8 am. Zoom link at dfr.oregon.gov/pdab

#Cosentyx #Creon #Vraylar #Trulicity #LantusSoloStar #HealthPolicy

3 0 0 0
Nanakimmyg
Nanakimmyg
@greetings4u.bsky.social
3 months ago

My endocrinologist switched me over from #trulicity to #monjurno, and now, every time I eat regardless of whatever it may be, I get nauseous.

0 0 0 0
Duty Free Meds
Duty Free Meds
@dutyfreemeds.bsky.social
5 months ago
Post image

Trulicity Side Effects Explained

Curious about what people may experience with Trulicity? We explore the common side effects, how serious they usually are, and when to check in with a healthcare provider.

dutyfreemeds.com/what-are-the...

------
#Trulicity #WeightLoss #Diabetes #TD2

2 1 0 0
Oregon Coalition for Affordable Prescriptions
Oregon Coalition for Affordable Prescriptions
@affordablerxor.bsky.social
5 months ago
Green background, white border, white text says Program Updates Sarah Young will be the new Executive Director of PDAB + Drug Price Transparency Program. Michelle Coder (Mount Loma Health) selected to join the board; first meeting Oct. 15, pending Senate confirmation. Dr. Dan Hartung, Dr. Chris Layman & Dan Kennedy reappointed through Dec. 2029. 9th Circuit upheld OR’s HB 4005 drug price transparency law, affirming state authority to collect price increase data (critical for PDAB’s work). Icon of a gavel

Green background, white border, white text says Program Updates Sarah Young will be the new Executive Director of PDAB + Drug Price Transparency Program. Michelle Coder (Mount Loma Health) selected to join the board; first meeting Oct. 15, pending Senate confirmation. Dr. Dan Hartung, Dr. Chris Layman & Dan Kennedy reappointed through Dec. 2029. 9th Circuit upheld OR’s HB 4005 drug price transparency law, affirming state authority to collect price increase data (critical for PDAB’s work). Icon of a gavel

Green background, white border, white text says Draft Policy Ideas PDAB past wins: capped insulin at $35/month, made PBMs report more data. New Ideas: One PBM for Medicaid → lower costs and better access Change PBM payment system → more transparency Audit 340B program → more transparency OHA expert may present on the Array RX system. Discussion about how studying the entire drug delivery system might mean adding new voices to the board. Staff will compile ideas for next month. Icon of two speech bubbles

Green background, white border, white text says Draft Policy Ideas PDAB past wins: capped insulin at $35/month, made PBMs report more data. New Ideas: One PBM for Medicaid → lower costs and better access Change PBM payment system → more transparency Audit 340B program → more transparency OHA expert may present on the Array RX system. Discussion about how studying the entire drug delivery system might mean adding new voices to the board. Staff will compile ideas for next month. Icon of two speech bubbles

Green background, white border, white text says Affordability Reviews Jardiance: Approved in 2014, patent ends 2026 On Medicare price negotiation list starting 2026 Price has gone up ~5% each year since 2018 PDAB noted payers get big discounts (≈60%) Mounjaro: Approved in 2022, patents run into the 2030s Not on Medicare price list Price rising ~5% per year PDAB discussed patient struggles with insurance coverage leading to treatment gaps Ozempic: Approved in 2017, patents expire 2025–2028 On Medicare price list starting 2027 Price rising ~5% per year PDAB questioned a sudden 2020–21 price dip and noted pharmacies sometimes paying above list price Icon of a prescription drug bottle with two pills on the outside

Green background, white border, white text says Affordability Reviews Jardiance: Approved in 2014, patent ends 2026 On Medicare price negotiation list starting 2026 Price has gone up ~5% each year since 2018 PDAB noted payers get big discounts (≈60%) Mounjaro: Approved in 2022, patents run into the 2030s Not on Medicare price list Price rising ~5% per year PDAB discussed patient struggles with insurance coverage leading to treatment gaps Ozempic: Approved in 2017, patents expire 2025–2028 On Medicare price list starting 2027 Price rising ~5% per year PDAB questioned a sudden 2020–21 price dip and noted pharmacies sometimes paying above list price Icon of a prescription drug bottle with two pills on the outside

Green background, white border, white text says Affordability Reviews Rybelsus: Approved in 2017, patents through 2039 On Medicare price list starting 2027 Price rising ~5% per year PDAB flagged strict use instructions (empty stomach, specific water, wait time) as a barrier for patients Trulicity: Approved in 2014, no active patents Not on Medicare price list Price has barely risen (~0.6% per year) PDAB noted Medicare patients may still pay more than others Overall, PDAB heard from staff and providers that transparency remains limited in 340B reporting, with many declining to share payment data.

Green background, white border, white text says Affordability Reviews Rybelsus: Approved in 2017, patents through 2039 On Medicare price list starting 2027 Price rising ~5% per year PDAB flagged strict use instructions (empty stomach, specific water, wait time) as a barrier for patients Trulicity: Approved in 2014, no active patents Not on Medicare price list Price has barely risen (~0.6% per year) PDAB noted Medicare patients may still pay more than others Overall, PDAB heard from staff and providers that transparency remains limited in 340B reporting, with many declining to share payment data.

On Friday the #Oregon #PDAB met. Here are the Highlights:
➡️New executive director and board member
➡️Draft policy ideas
➡️Discussions about the cost Oregonians pay for #Jardiance, #Mounjaro, #Ozempic, #Rybelsus, #Trulicity
➡️ Final comments for affordability reviews by Oct 15
#HealthPolicySky

0 0 1 0
Oregon Coalition for Affordable Prescriptions
Oregon Coalition for Affordable Prescriptions
@affordablerxor.bsky.social
6 months ago
A red rectangle at the top of the page with a white icon of a calendar with a clock and text that says PdAB public comments are due on Monday Sept. 15 at 8 am! Below is a light blue icon of a paper with a dollar sign and a down arrow. White background with black text says The Oregon Prescription Drug Affordability Board (PDAB) is reviewing these drugs to determine if they strain Oregon patients or our health care system at their September 17 meeting. If you or someone you know has taken: Jardiance (Empagliflozin) Mounjaro (Tirzepatide) Ozempic (Semaglutide) Rybelsus (Semaglutide) Trulicity (Dulaglutide) Consider sharing your experience with the Oregon PDAB at the link below. bit.ly/or-pdab-comment

A red rectangle at the top of the page with a white icon of a calendar with a clock and text that says PdAB public comments are due on Monday Sept. 15 at 8 am! Below is a light blue icon of a paper with a dollar sign and a down arrow. White background with black text says The Oregon Prescription Drug Affordability Board (PDAB) is reviewing these drugs to determine if they strain Oregon patients or our health care system at their September 17 meeting. If you or someone you know has taken: Jardiance (Empagliflozin) Mounjaro (Tirzepatide) Ozempic (Semaglutide) Rybelsus (Semaglutide) Trulicity (Dulaglutide) Consider sharing your experience with the Oregon PDAB at the link below. bit.ly/or-pdab-comment

Reminder to submit public comment to the next Oregon Prescription Drug Affordability Board (PDAB) meeting before Monday at 8 am!

Link to submit comments: bit.ly/or-pdab-comment

#Oregon #PDAB #PrescriptionDrugAffordability #Jardiance #Mounjaro #Ozempic #Rybelsus
#Trulicity #PublicComment

0 0 0 0
Oregon Coalition for Affordable Prescriptions
Oregon Coalition for Affordable Prescriptions
@affordablerxor.bsky.social
6 months ago
Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark purple box with a syringe with lime green liquid and white text reads Trulicity Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board

Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark purple box with a syringe with lime green liquid and white text reads Trulicity Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board

Have you or someone you know paid a high price for #Trulicity?

The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky

0 0 0 0
Superdave!
Superdave!
@wx1g.bsky.social
6 months ago

#today I just stabbed myself in the gut, as I do every Sunday. #GLP1 #trulicity That sting tells me it's working!!

0 0 0 0